Imeglimin is an oral anti-diabetic medication approved for use in Japan in June 2021. It is a pharmaceutical raw material used in the manufacture of finished dosage forms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Imeglimin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Imeglimin hydrochloride
pharmaceutical raw material
Potassium bromide
pharmaceutical raw material
Thymosin beta 4 acetate
pharmaceutical raw material
Trimagnesium dicitrate
pharmaceutical raw material
Tin(II) fluoride
pharmaceutical raw material
Imeglimin (hydrochloride)
pharmaceutical raw material
The international HS code for Imeglimin (CAS 775351-65-0) is 2933.69.
2933.69
2933 69 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine
GFICWFZTBXUVIG-SCSAIBSYSA-N
C[C@@H]1N=C(NC(=N1)N(C)C)N
Sourcing Imeglimin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.